New technologies, therapies and medicines are emerging: this includes regenerative medicine, which encompasses gene therapy, cell therapy and tissue-engineered products, advanced diagnostics tools such as new genetic technologies, and the development of nanomedicines, with the purpose of more personalized treatments.

The conference will bring together world-renowned experts from the fields of cell and gene therapy, molecular targeted therapies, advanced therapeutic and diagnostic technologies to illustrate the ongoing research and to drive scientific knowledge in the area of translational research and early clinical applications. Specifically, it will shed light into the development phases, clinical trials, and regulatory aspects of these therapies, particularly in the field of Oncology, Hematology, Immunology, Inflammatory and Autoimmune disorders, to engender better and more personalized treatment options, and ultimately bring important health benefits.

Leading experts from Middle East, Europe and US will address different aspects of these topic themes.

 

This activity is an Accredited Group Learning Activity (Category 1) as defined by the Qatar Council for Healthcare Practitioners – Accreditation Department and is approved for a maximum of 14.75 hour(s)

 

This conference will be attended by physicians, nurses, pharmacists, allied health providers and others (e.i. scientists and medical students) who care for patients with oncological, hematological, immunology, inflammatory and autoimmune disorders.

The conference is supported by the Cell Therapy and Immunobiology Working Party (CTIWP) of the European Society for Blood and Marrow Transplantation (EBMT).

 

Educational objectives

  • Describe the available somatic cell therapies: development phases, clinical trials, and regulatory aspects;
  • Describe the available gene Therapies: development phases, clinical trials, and regulatory aspects;
  • Describe the available molecular targeted therapies: development phases, clinical trials, and regulatory aspects;
  • Discuss advanced therapeutic and diagnostic technologies in diabetes, surgery, etc.              

 

Scientific Sessions

  • Advanced Therapies: Quality and Compliance Issues
  • Molecular Targeted Therapies: new weapons are available to increase the efficacy
  • The evolution of immunotherapy for cancer treatment: where are we?
  • Cell Therapy and Adoptive Cell Therapy: a cell for every disease?
  • The future of the future. Gene therapy: new and old methods for patients’ gene correction
  • CAR-T cells: manufacture and applications of cancer-targeted cell therapy.
  • Novel transplant approaches: tailoring cells for clinical needs.
  • SIDRA at the forefront of advanced technologies

Keynote Lectures by

  • Gianpietro Dotti (North Carolina University, US)
  • Soldano Ferrone (Harvard Medical School, Boston, US)
  • Adrian Thrasher (UCL Great Ormond Street Institute of Child Health, UK)

 

 

Registration Packages

 

Conference Pricing             General Admission             Student            

Early bird registration                    USD 150                                    USD 50

Registration after 15 Oct             USD 250                                    USD 80

On-site registration                        USD 250                                    USD 120

** On-site registration is open upon availability

 

Students are NOT eligible for CME credits

For Sidra staff registration, please contact Mrs. Nelly EL Mistekawy nelmistekawy@sidra.org


 

The Scientific Organizing Committee

Chiara Cugno, Director Clinical Research Center

Luciano Callegaro, Director- Clinical Trail and Outcome Program

Rachel Park, Clinical Nurse Manager – Oncology/ BMT

Sara Deola, Investigator

Bernice Lo, Investigator

Khalid Hussain, Program Director – Research in Children’s Services CMG

Cristina Maccalli, Staff Scientist

Mamoun Elawad, Division Chief – Gastroenterology

Asim Belgaumi, Deputy Division Chief – Pediatric Hematology, Oncology

Anish Nicholas Patel, Operations Manager- Department of Pharmacy

The Supporting Organizing Committee

Nelly EL Mistekawy, CRO Office Manager

Maria Theresa Brunsman, Executive Assistant

Irina Chepilevskaya, Project Analyst

Lara Djansezian, Business Analyst

Maricris Salud, Sr. Admin Assistant

Nevin Amin, Sr. Admin Assistant

Rana Hamada, Executive Assistant

Hamda Zain Al Abdeen, Communications Event Specialist

Fadi Hamsho, Lead – Web Projects & Development

 

 

 

Why Exhibit?

The Advanced Therapies in Healthcare Conference and Exhibition will provide an exceptional opportunity for exhibitors to uniquely position themselves and showcase their products and services to their target audience and markets. As a contributor and exhibitor at the symposium you will be able to reach an international audience of key researchers, clinicians and healthcare providers and enhance your company profile in a fast growing local market.

Coffee breaks and lunches will all take place on the exhibition floor promoting frequent and repeated opportunities for the delegates to visit your exhibits in prime locations and engage with your brand.

CONTINUE
 

Visa requirement

Visa application to attend this symposium is the responsibility of each Individual.  However, we are able to provide some assistance in this if needed.

Online visa applications to Qatar:   https://qatar.visahq.com

For further assistance, please contact Mrs. Rana Hamada at rhamada@sidra.org

 

Recommended Hotel to book with a discounted room rate

FOUR SEASONS HOTEL – DOHA

The Corniche, P.O. Box 24665, Doha, Qatar

Tel. +(974) 4494 8888

Fax. +(974) 4494 8282

 





Programme Schedule

Download the programme schedule for this event

Please check this section on regular basis for updates

Starts / Ends

On       October 28, 2017
Until       October 29, 2017

7:00 am – 5:00 pm


50 - 250

Eventbrite - Advanced Therapies in Healthcare (CME accredited)



Venue Location

FOUR SEASONS HOTEL
The Corniche
Al Mirqab Ballroom
DOHA, QATAR


Sponsors


Exhibitors